# A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

> **NCT06060977** · PHASE1,PHASE2 · COMPLETED · sponsor: **Inmagene LLC** · enrollment: 29 (actual)

## Conditions studied

- Alopecia Areata (AA)

## Interventions

- **DRUG:** IMG-007

## Key facts

- **NCT ID:** NCT06060977
- **Lead sponsor:** Inmagene LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-25
- **Primary completion:** 2025-01-14
- **Final completion:** 2025-01-14
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06060977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06060977, "A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06060977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*